Drug intelligence / Profile preview

pseudoginsenoside gq

Development stage
Phase 2
Lead developer
Jilin Huakang Pharmaceutical
Modality
Small Molecules
Administration
Intravenous
01

Overview

Pseudoginsenoside GQ is a dammarane-type triterpene saponin isolated from the leaves of Panax species, specifically developed by Jilin Huakang Pharmaceutical for cardiovascular indications. It is primarily investigated for the treatment of stable angina pectoris and coronary heart disease. The compound exhibits significant cardioprotective properties, including the ability to improve myocardial ischemia, reduce myocardial oxygen consumption, and protect cardiomyocytes from oxidative stress and apoptosis. Clinical evaluation in China, particularly in its injectable form, has focused on its efficacy in relieving symptoms of chronic stable angina and improving cardiac function in patients with coronary heart disease.

Other names
Pseudoginsenoside GQ拟人参皂苷GQ
02

Targets

CACNA1C (Voltage-dependent L-type calcium channel subunit alpha-1C)LTCC (Voltage-gated calcium channel (L-type))

Beyond the preview

Go deeper on pseudoginsenoside gq.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pseudoginsenoside gq.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call